Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development - Image 1

Price loading...

Wiley Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development

Name: Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development
Brand: Wiley

Other Branches of Medicine

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

A comprehensive review of contemporary antisense oligonucleotides drugs and therapeutic principles, methods, applications, and research Oligonucleotide-based drugs, in particular antisense oligonucleotides, are part of a growing number of pharmaceutical and biotech programs progressing to treat a wide range of indications including cancer, cardiovascular, neurodegenerative, neuromuscular, and respiratory diseases, as well as other severe and rare diseases. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide covering all key aspects of this increasingly popular area of pharmacology and biotech and pharma research, from the basic science behind antisense oligonucleotides chemistry, toxicology, manufacturing, to safety assessments, the design of therapeutic protocols, to clinical experience. Antisense oligonucleotides are single strands of DNA or RNA that are complementary to a chosen sequence. While the idea of antisense oligonucleotides to target single genes dates back to the 1970's, most advances have taken place in recent years. The increasing number of antisense oligonucleotide programs in clinical development is a testament to the progress and understanding of pharmacologic, pharmacokinetic, and toxicologic properties as well as improvement in the delivery of oligonucleotides. This valuable book reviews the fundamentals of oligonucleotides, with a focus on antisense oligonucleotide drugs, and reports on the latest research underway worldwide. • Helps readers understand antisense molecules and their targets, biochemistry, and toxicity mechanisms, roles in disease, and applications for safety and therapeutics • Examines the principles, practices, and tools for scientists in both pre-clinical and clinical settings and how to apply them to antisense oligonucleotides • Provides guidelines for scientists in drug design and discovery to help improve efficiency, assessment, and the success of drug candidates • Includes interdisciplinary perspectives, from academia, industry, regulatory and from the fields of pharmacology, toxicology, biology, and medicinal chemistry Oligonucleotide-Based Drugs and Therapeutics belongs on the reference shelves of chemists, pharmaceutical scientists, chemical biologists, toxicologists and other scientists working in the pharmaceutical and biotechnology industries. It will also be a valuable resource for regulatory specialists and safety assessment professionals and an important reference for academic researchers and post-graduates interested in therapeutics, antisense therapy, and oligonucleotides.

Product Specifications

Brand: Wiley
Format: hardcover
ASIN: 1118537335
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 22 July 2016
Listed Since: 02 October 2012

Barcode

No barcode data available

Wiley Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition

Handbook of Analysis of Oligonucleotides and Related Products

Handbook of Analysis of Oligonucleotides and Related Products

Protocols for Oligonucleotides and Analogs: Synthesis and Properties: 20 (Methods in Molecular Biology, 20)

Drug Development for Gene Therapy: Translational Biomarkers, Bioanalysis, and Companion Diagnostics

Therapeutic Oligonucleotides: Transcriptional and Translational Strategies for Silencing Gene Expression: Transcriptional and Translational Strategies ... (Annals of the New York Academy of Sciences)

Oligonucleotide-Based Therapies: Methods and Protocols: 2036 (Methods in Molecular Biology, 2036)

Development of Therapeutic Agents Handbook: 8 (Pharmaceutical Development Series)

Wiley - Biological Drug Products: Development and Strategies

Enzymatic and Chemical Synthesis of Nucleic Acid Derivatives

Oligonucleotide Therapeutics: First Annual Meeting of the Oligonucleotide Therapeutics Society (Annals of the New York Academy of Sciences)

Drug Discovery Research: New Frontiers in the Post-Genomic Era

Wiley - Contemporary Accounts in Drug Discovery and Development

Bioanalytical Aspects in Biological Therapeutics (Wiley on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods)

Basic Principles of Drug Discovery and Development

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Chemistry and Pharmacology of Anticancer Drugs

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry of Biologically Potent Natural Products and Synthetic Compounds (Emerging Trends in Medicinal and Pharmaceutical Chemistry)

Clinical Trials of Genetic Therapy with Antisense DNA and DNA Vectors

RNA as a Drug Target: The Next Frontier for Medicinal Chemistry (Methods & Principles in Medicinal Chemistry)

mRNA Therapeutics: Foundations, Innovations, and Clinical Applications

RNA Therapeutics: Function, Design, and Delivery: 629 (Methods in Molecular Biology, 629)